An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg, Bo Wang, Yonit Lavin, Talia H. Swartz, Deepu Madduri, Aryeh Stock, Thomas U. Marron, Hui Xie, Manishkumar Patel, Kevin Tuballes, Oliver Van Oekelen, Adeeb Rahman, Patricia Kovatch, Judith A. Aberg, Eric E. Schadt, Sundar Jagannath, Madhu Mazumdar, Alexander W. Charney, Adolfo Firpo‐Betancourt, Damodara Rao Mendu, Jeffrey S. Jhang, David L. Reich, Keith Sigel, Carlos Cordon‐Cardo, Marc Feldmann, Samir Parekh, Miriam Mérad, Sacha Gnjatic
Topics & Concepts
MedicineInternal medicineDiseaseCytokineTumor necrosis factor alphaCohortProspective cohort studySeverity of illnessImmunologyCohort studyClinical trialCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research